Ueli Schibler

Title: Ueli Schibler: Innovator in Bioluminescence Monitoring and Nucleic Acid Quantification

Introduction

Ueli Schibler is a notable inventor based in Borex, Switzerland. He has made significant contributions to the fields of bioluminescence monitoring and nucleic acid quantification. With a total of 2 patents, his work has advanced scientific understanding and practical applications in these areas.

Latest Patents

One of Schibler's latest patents is the "In vivo bioluminescence monitoring apparatus." This innovative apparatus allows for real-time monitoring of bioluminescence in conscious small animals. It features a light-tight enclosure designed to house the animal while allowing it to move freely. The system includes a bioluminescence detector that connects to a data processing system, along with a life-sustaining system to keep the animal alive for extended periods.

Another significant patent is the "Method for identifying and/or quantifying expression of nucleic acid." This invention outlines methods for quantifying or identifying nucleic acid molecules in samples. The process involves using double-stranded additions to nucleic acid molecules, followed by cross-hybridization and identification of specific types of molecules.

Career Highlights

Throughout his career, Ueli Schibler has worked with prominent organizations, including Roche Diagnostics GmbH and Université de Genève. His experience in these institutions has contributed to his expertise and the development of his innovative patents.

Collaborations

Schibler has collaborated with notable colleagues such as Daniel Lavery and Andre Liani. These partnerships have likely enriched his research and development efforts.

Conclusion

Ueli Schibler's contributions to bioluminescence monitoring and nucleic acid quantification demonstrate his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a commitment to improving research methodologies and applications in these critical fields.